Literature DB >> 6294340

Translational control of vesicular stomatitis virus protein synthesis: isolation of an mRNA-sequestering particle.

C A Rosen, H L Ennis, P S Cohen.   

Abstract

An mRNA-ribonucleoprotein particle (mRNP) was found in vesicular stomatitis virus (VSV)-infected Chinese hamster ovary cells. The particle was present 3 and 4.5 h after infection but was barely discernible at 2 h. The mRNP (buoyant density, 1.56 g/cm3), which cosedimented with viral nucleocapsid in a sucrose density gradient at approximately 120 to 160S, was separable from nucleocapsid (buoyant density, 1.31 g/cm3) by CsCl density gradient centrifugation. It contained all five VSV mRNAs and, almost exclusively, viral N protein. Some host mRNA and host protein was also present in the particle. The intact mRNP was incapable of stimulating protein synthesis in an in vitro protein-synthesizing system, although the VSV mRNA isolated from the particle by phenol extraction was functional in vitro. In contrast, intact polysomes stimulated cell-free protein synthesis to the same extent as purified polysomal mRNA. By 4.5 h after infection, 97% of the functional mRNA in vivo was associated with the mRNP, and only 3% was on polysomes. The amount of polysomal mRNA at 4.5 h after infection was only 31% of that found at 2 h after infection; this was reflected by the 76% decrease observed in the rate of in vivo protein synthesis at 4.5 h relative to that found at 2 h. Thus, it appears that the mRNP serves as an organelle which sequesters the large excess of VSV mRNA that is normally made during secondary transcription.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6294340      PMCID: PMC256352     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Analysis of the RNA of defective VSV particles.

Authors:  G Stamminger; R A Lazzarini
Journal:  Cell       Date:  1974-09       Impact factor: 41.582

2.  In vitro synthesis of RNA that contains polyadenylate by virion-associated RNA polymerase of vesicular stomatitis virus.

Authors:  A K Banerjee; D P Rhodes
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

3.  Proteins of vesicular stomatitis virus. 3. Intracellular synthesis and extracellular appearance of virus-specific proteins.

Authors:  C Y Kang; L Prevec
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

4.  Ribonucleic acid synthesis of vesicular stomatitis virus. 3. Multiple complementary messenger RNA molecules.

Authors:  A S Huang; D Baltimore; M Stampfer
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

5.  Polysomal ribonucleic acid of vesicular stomatitis virus-infected HeLa cells.

Authors:  J A Mudd; D F Summers
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

6.  Initiation of polyribosome formation in poliovirus-infected HeLa cells.

Authors:  A S Huang; D Balitmore
Journal:  J Mol Biol       Date:  1970-02-14       Impact factor: 5.469

7.  Proteins of vesicular stomatitis virus. I. Polyacrylamide gel analysis of viral antigens.

Authors:  C Y Kang; L Prevec
Journal:  J Virol       Date:  1969-04       Impact factor: 5.103

8.  Efficient translation of tobacco mosaic virus RNA and rabbit globin 9S RNA in a cell-free system from commercial wheat germ.

Authors:  B E Roberts; B M Paterson
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

9.  Ribonucleic acid synthesis of vesicular stomatitis virus. I. Species of ribonucleic acid found in Chinese hamster ovary cells infected with plaque-forming and defective particles.

Authors:  M Stampfer; D Baltimore; A S Huang
Journal:  J Virol       Date:  1969-08       Impact factor: 5.103

10.  Inhibition of protein synthesis in L cells infected with vesicular stomatitis virus.

Authors:  G W Wertz; J S Youngner
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

View more
  12 in total

Review 1.  Cytopathogenesis and inhibition of host gene expression by RNA viruses.

Authors:  D S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

2.  NFAR-1 and -2 modulate translation and are required for efficient host defense.

Authors:  Ingrid Pfeifer; Rachel Elsby; Marilyn Fernandez; Paula A Faria; Daniel R Nussenzveig; Izidor S Lossos; Beatriz M A Fontoura; W David Martin; Glen N Barber
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-12       Impact factor: 11.205

Review 3.  miRNAs: effectors of environmental influences on gene expression and disease.

Authors:  Alice Hudder; Raymond F Novak
Journal:  Toxicol Sci       Date:  2008-02-16       Impact factor: 4.849

4.  Unusual transcripts in La Crosse virus-infected cells and the site for nucleocapsid assembly.

Authors:  R Raju; D Kolakofsky
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

5.  Adenovirus proteins associated with mRNA and hnRNA in infected HeLa cells.

Authors:  S A Adam; G Dreyfuss
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

6.  Interaction of mRNA with proteins in vesicular stomatitis virus-infected cells.

Authors:  S A Adam; Y D Choi; G Dreyfuss
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

7.  Specific interaction between coronavirus leader RNA and nucleocapsid protein.

Authors:  S A Stohlman; R S Baric; G N Nelson; L H Soe; L M Welter; R J Deans
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

8.  Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription.

Authors:  R S Baric; G W Nelson; J O Fleming; R J Deans; J G Keck; N Casteel; S A Stohlman
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

9.  New mRNAs are preferentially translated during vesicular stomatitis virus infection.

Authors:  Zackary W Whitlow; John H Connor; Douglas S Lyles
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

10.  Assembly and transcription of synthetic vesicular stomatitis virus nucleocapsids.

Authors:  S A Moyer; S Smallwood-Kentro; A Haddad; L Prevec
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.